| Members |
targetComponentId |
| Injection of inert substance into organ NOC |
Injection |
| Injection of inert substance into subcutaneous tissue NEC |
Injection of inert substance into subcutaneous tissue (procedure) |
| Injection of other destructive substance into lesion of organ NOC |
Injection |
| Injection of other destructive substance into organ NOC |
Injection |
| Injection of other substance into organ NOC |
Injection |
| Injection of other substance into organ NOC NOS |
Injection |
| Injection of other substance into organ NOC OS |
Injection |
| Injection of radiocontrast substance into sinus track from organ NOC |
Injection of radiocontrast material (procedure) |
| Injection of sclerosing substance into lesion of organ NOC |
Injection of sclerosing agent |
| Injection of sclerosing substance into organ NOC NOS |
Injection of sclerosing agent |
| Injection of spinal canal |
Intrathecal injection |
| injektion i spinalt intervertebralrum med kymodiaktin |
Injection of spinal intervertebral space with chymopapain |
| Injection of steroid for local action NEC |
Injection of steroid for local action (procedure) |
| injektion av substans |
Injection |
| injektion i vävnad för lokal effekt |
Injection into body tissue for local action |
| injektion av substans i cerebrospinalvätskan |
Injection of brain |
| injektion av substans i fistel |
Injection |
| injektion i nervganglion |
Nerve injection |
| injektion av substans i retrobulbärt rum |
Injection of orbit |
| injektion i tunntarmen |
Abdomen injection |
| subkutan injektion |
Injection into subcutaneous tissue (procedure) |
| injektion av substans i brösthålan |
Thorax injection |
| injektion av substans i cavum uteri |
Injection of uterus |
| injektion av substans i hjärnventrikel |
Injection of brain |
| Injection of tendon |
Injection of tendon sheath |
| injektion av läkemedel |
Injection of drug or medicament (procedure) |
| Injection of therapeutic inclusion substance into organ NOC |
Injection |
| Injection of therapeutic inclusion substance into organ NOC, NOS |
Injection |
| Injection of therapeutic substance |
Injection of drug or medicament (procedure) |
| Injection of therapeutic substance NOS |
Injection |
| injektion av läkemedel i cerebrospinalvätskan |
Injection of brain |
| injektion av läkemedel i subkutan vävnad |
Injection into subcutaneous tissue (procedure) |
| Injection of therapeutic substance into subcutaneous tissue NEC |
Injection into subcutaneous tissue (procedure) |
| Injection of vein |
Intravenous injection |
| reaktion på injektionsställe |
Injection site disorder |
| Injection therapy |
Injection - action |
| Injury at C1-C4 level with other specified spinal cord injury and without bone injury |
Injury at C1-C4 level with spinal cord injury AND without bone injury |
| Injury at C5-C7 level with other specified spinal cord injury and without bone injury |
Injury at C5-C7 level with spinal cord injury AND without bone injury |
| Injury of hand, except finger |
Injury of hand |
| skada på flera ställen på kolon och/eller rektum med sårskada in till bukhålan |
Injury of multiple sites of cecum and/or colon and/or rectum with open wound into abdominal cavity (disorder) |
| Injury of neck including whiplash |
Injury of neck |
| Injury of nerve roots AND/OR spinal plexus |
Injury of peripheral nerve (disorder) |
| Injury of other specified branch of celiac axis, NEC |
Injury of branch of celiac axis |
| Injury of peripheral nerve of pelvic girdle AND/OR lower limb |
Injury of peripheral nerve (disorder) |
| Injury of peripheral nerve of shoulder girdle AND/OR upper limb |
Injury of peripheral nerve (disorder) |
| Injury of portal AND/OR splenic veins |
Injury of vein |
| inre halvan av dentinet |
Inner third of dentin |
| inositolnikotinatallergi |
Allergy to inositol |
| förgiftning orsakad av insekt |
Poisoning due to insect venom |
| inläggning av Baerveldtventil i främre ögonkammare |
Insertion of drainage tube into anterior chamber |
| insättning av peritoneovenös Denvershunt |
Insertion of peritoneovenous shunt |
| insättning av Le Veenshunt |
Insertion of peritoneovenous shunt |
| insättning av Norplant |
Insertion of subcutaneous contraceptive (procedure) |
| inläggning av biventrikulär permanent pacemaker under röntgengenomlysning |
Implantation of cardiac biventricular permanent pacemaker using fluoroscopic guidance |
| Insertion of catheter in anterior chamber of eye for permanent drainage in glaucoma |
Insertion of drainage tube into anterior chamber |
| Insertion of extravascular umbrella of inferior vena cava, complete |
Insertion of intravascular umbrella of inferior vena cava, complete |
| Insertion of extravascular umbrella of inferior vena cava, partial |
Insertion of intravascular umbrella of inferior vena cava, partial |
| insättning av oral apparatur för personer med funktionsnedsättning |
Insertion of intraoral appliance |
| inläggning av permanent pacemaker under röntgengenomlysning |
Implantation of permanent cardiac pacemaker using fluoroscopic guidance (procedure) |
| Insertion of prosthesis into organ NOC |
Insertion procedure (procedure) |
| Insertion of silicon plug |
Insertion - action (qualifier value) |
| Inspection - physical examination - action (qualifier value) |
Inspection - action |
| instillation av läkemedel i blåsan |
Instillation of bladder |
| Instrumental insertion |
Insertion - action (qualifier value) |
| Instrumental removal of products of conception from delivered uterus NOS |
Instrumental removal of products of conception from delivered uterus |
| Instrumentation - action |
Action |
| otillräcklig mängd vävnad för att fastställa högsta patologiska T-kategori |
pTX |
| insufflator av typ 2-plast |
Plastic insufflator (physical object) |
| insufflator av typ 4-plast |
Plastic insufflator (physical object) |
| bovint insulinextrakt |
Beef insulin-containing product |
| humant insulinextrakt |
Human insulin-containing product |
| porcint insulinextrakt |
Pork insulin-containing product |
| Insulin antibody |
Anti-insulin antibody |
| bifasiskt humant isofaninsulin 10/90, 100 E/ml, injektionsvätska, lösning, cylinderampull 1,5 ml |
Product containing precisely salmon calcitonin 200 unit/1 actuation conventional release nasal spray (clinical drug) |
| bifasiskt humant isofaninsulin 10/90, 100 E/ml, injektionsvätska, lösning, cylinderampull 3 ml |
Product containing precisely salmon calcitonin 200 unit/1 actuation conventional release nasal spray (clinical drug) |
| bifasiskt humant isofaninsulin 10/90, 100 E/ml, injektionsvätska, lösning, förfylld penna 3 ml |
Product containing precisely salmon calcitonin 200 unit/1 actuation conventional release nasal spray (clinical drug) |
| bifasiskt humant isofaninsulin 15/85, 100 E/ml, injektionsvätska, lösning, cylinderampull 3 ml |
Product containing precisely human isophane insulin 85 unit/1 milliliter and recombinant human regular insulin 15 unit/1 milliliter conventional release suspension for injection (clinical drug) |
| bifasiskt humant isofaninsulin 15/85, 100 E/ml, injektionsvätska, lösning, förfylld penna 3 ml |
Product containing precisely human isophane insulin 85 unit/1 milliliter and recombinant human regular insulin 15 unit/1 milliliter conventional release suspension for injection (clinical drug) |
| bifasiskt humant isofaninsulin 15/85, 100 E/ml, injektionsvätska, lösning, flaska 5 ml |
Product containing precisely human isophane insulin 85 unit/1 milliliter and recombinant human regular insulin 15 unit/1 milliliter conventional release suspension for injection (clinical drug) |
| bifasiskt humant isofaninsulin 20/80, 100 E/ml, injektionsvätska, lösning, cylinderampull 1,5 ml |
Product containing precisely human isophane insulin 80 unit/1 milliliter and recombinant human regular insulin 20 unit/1 milliliter conventional release suspension for injection (clinical drug) |
| bifasiskt humant isofaninsulin 20/80, 100 E/ml, injektionsvätska, lösning, cylinderampull 3 ml |
Product containing precisely human isophane insulin 80 unit/1 milliliter and recombinant human regular insulin 20 unit/1 milliliter conventional release suspension for injection (clinical drug) |
| bifasiskt humant isofaninsulin 20/80, 100 E/ml, injektionsvätska, lösning, förfylld penna 3 ml |
Product containing precisely human isophane insulin 80 unit/1 milliliter and recombinant human regular insulin 20 unit/1 milliliter conventional release suspension for injection (clinical drug) |
| bifasiskt humant isofaninsulin 25/75, 100 E/ml, injektionsvätska, lösning, cylinderampull 3 ml |
Product containing precisely human isophane insulin 75 unit/1 milliliter and recombinant human regular insulin 25 unit/1 milliliter conventional release suspension for injection (clinical drug) |
| bifasiskt humant isofaninsulin 25/75, 100 E/ml, injektionsvätska, lösning, förfylld penna 3 ml |
Product containing precisely human isophane insulin 75 unit/1 milliliter and recombinant human regular insulin 25 unit/1 milliliter conventional release suspension for injection (clinical drug) |
| bifasiskt humant isofaninsulin 25/75, 100 E/ml, injektionsvätska, lösning, flaska 5 ml |
Product containing precisely human isophane insulin 75 unit/1 milliliter and recombinant human regular insulin 25 unit/1 milliliter conventional release suspension for injection (clinical drug) |
| bifasiskt humant isofaninsulin 30/70, 100 E/ml, injektionsvätska, lösning, cylinderampull 1,5 ml |
Product containing precisely human isophane insulin 70 unit/1 milliliter and recombinant human regular insulin 30 unit/1 milliliter conventional release solution for injection (clinical drug) |
| bifasiskt humant isofaninsulin 30/70, 100 E/ml, injektionsvätska, lösning, flaska 10 ml |
Product containing precisely human isophane insulin 70 unit/1 milliliter and recombinant human regular insulin 30 unit/1 milliliter conventional release solution for injection (clinical drug) |
| bifasiskt humant isofaninsulin 30/70, 100 E/ml, injektionsvätska, lösning, förfylld penna 3 ml |
Product containing precisely human isophane insulin 70 unit/1 milliliter and recombinant human regular insulin 30 unit/1 milliliter conventional release solution for injection (clinical drug) |
| bifasiskt humant isofaninsulin 40/60, 100 E/ml, injektionsvätska, lösning, cylinderampull 1,5 ml |
Product containing precisely human isophane insulin 60 unit/1 milliliter and recombinant human regular insulin 40 unit/1 milliliter conventional release suspension for injection (clinical drug) |
| bifasiskt humant isofaninsulin 40/60, 100 E/ml, injektionsvätska, lösning, cylinderampull 3 ml |
Product containing precisely human isophane insulin 60 unit/1 milliliter and recombinant human regular insulin 40 unit/1 milliliter conventional release suspension for injection (clinical drug) |
| bifasiskt humant isofaninsulin 40/60, 100 E/ml, injektionsvätska, lösning, förfylld penna 3 ml |
Product containing precisely human isophane insulin 60 unit/1 milliliter and recombinant human regular insulin 40 unit/1 milliliter conventional release suspension for injection (clinical drug) |
| bifasiskt humant isofaninsulin 50/50, 100 E/ml, injektionsvätska, lösning, cylinderampull 1,5 ml |
Product containing precisely human isophane insulin 50 unit/1 milliliter and recombinant human regular insulin 50 unit/1 milliliter conventional release suspension for injection (clinical drug) |
| bifasiskt humant isofaninsulin 50/50, 100 E/ml, injektionsvätska, lösning, flaska 10 ml |
Product containing precisely human isophane insulin 50 unit/1 milliliter and recombinant human regular insulin 50 unit/1 milliliter conventional release suspension for injection (clinical drug) |
| bifasiskt humant isofaninsulin 50/50, 100 E/ml, injektionsvätska, lösning, cylinderampull 3 ml |
Product containing precisely human isophane insulin 50 unit/1 milliliter and recombinant human regular insulin 50 unit/1 milliliter conventional release suspension for injection (clinical drug) |
| bifasiskt humant isofaninsulin 50/50, 100 E/ml, injektionsvätska, lösning, förfylld penna 3 ml |
Product containing precisely human isophane insulin 50 unit/1 milliliter and recombinant human regular insulin 50 unit/1 milliliter conventional release suspension for injection (clinical drug) |
| bifasiskt humant isofaninsulin 50/50, 100 E/ml, injektionsvätska, lösning, flaska 5 ml |
Product containing precisely human isophane insulin 50 unit/1 milliliter and recombinant human regular insulin 50 unit/1 milliliter conventional release suspension for injection (clinical drug) |
| bifasiskt porcint isofaninsulin 30/70, 100 E/ml, injektionsvätska, lösning, flaska 10 ml |
Product containing precisely porcine isophane insulin 70 unit/1 milliliter and porcine regular insulin 30 unit/1 milliliter conventional release suspension for injection (clinical drug) |
| bifasiskt lisproinsulin 25/75, 100 E/ml, injektionsvätska, lösning, cylinderampull 3 ml |
Product containing precisely insulin lispro 25 unit/1 milliliter and insulin lispro protamine 75 unit/1 milliliter conventional release solution for injection (clinical drug) |
| bifasiskt lisproinsulin 25/75, 100 E/ml, injektionsvätska, lösning, förfylld penna 3 ml |
Product containing precisely insulin lispro 25 unit/1 milliliter and insulin lispro protamine 75 unit/1 milliliter conventional release solution for injection (clinical drug) |
| bifasiskt lisproinsulin 50/50, 100 E/ml, injektionsvätska, lösning, förfylld penna 3 ml |
Product containing precisely insulin lispro 50 unit/1 milliliter and insulin lispro protamine 50 unit/1 milliliter conventional release solution for injection (clinical drug) |
| Insulin isophane biphasic human 10/90 100units/ml injection 1.5ml cartridge |
Product containing precisely human isophane insulin 90 unit/1 milliliter and recombinant human regular insulin 10 unit/1 milliliter conventional release suspension for injection (clinical drug) |
FHIR